Qdot™ 605 Streptavidin Conjugate
Invitrogen™

Qdot™ 605 Streptavidin Conjugate

Qdot™ 605 streptavidin conjugateは、蛍光標識(Qdot™ナノ結晶)に共有結合したビオチン結合タンパク質(ストレプトアビジン)で構成されています。ストレプトアビジンはビオチンとの結合親和性が非常に高く詳細を見る
製品番号(カタログ番号)数量
Q10103MP50 μL
Q10101MP200 μL
製品番号(カタログ番号) Q10103MP
価格(JPY)
55,800
Each
数量:
50 μL
Qdot™ 605 streptavidin conjugateは、蛍光標識(Qdot™ナノ結晶)に共有結合したビオチン結合タンパク質(ストレプトアビジン)で構成されています。ストレプトアビジンはビオチンとの結合親和性が非常に高く、ストレプトアビジンのコンジュゲートは一般に、ビオチンのコンジュゲートと組み合わせてさまざまなタンパク質、タンパク質モチーフ、核酸、その他の分子の特異的検出に使用できます(たとえば、あるタンパク質標的に結合したビオチン化一次抗体を、蛍光標識したストレプトアビジンで検出できます)。これに類似した方法は、ウェスタンブロット、フローサイトメトリー、イメージングと顕微鏡検査、マイクロプレートアッセイなどの多くの検出プロトコルで使用され、標的分画化を行う精製ワークフローでも使用されています。Qdot™ナノクリスタルコンジュゲートは、1 µM溶液として使用できます。

Qdot™ストレプトアビジンコンジュゲートには、以下のような重要な特長があります。
ストレプトアビジン Qdot™ 605 コンジュゲートは、励起極大 ∼605 nmにあります
Qdot™ナノクリスタル1個あたり約5~10個のストレプトアビジン
非常に光安定性が高く、明るい蛍光
シングルライン励起源で効率的に励起
狭い発光、大きなストークスシフト
複数の色をご用意
ウェスタンブロット、フローサイトメトリー、イメージングと顕微鏡検査、マイクロプレートアッセイなどに最適

Qdot™ ナノクリスタルの特長
Qdot™ ストレプトアビジンコンジュゲートは、大きなサイズの高分子またはタンパク質 (∼15~20 nm) であり、ストレプトアビジン検出試薬の中で最も明るいクラスとなります。Qdot™ストレプトアビジンコンジュゲートは、半導体材料(CdSe)のナノメートルスケールの結晶を、材料の光学特性を向上させる半導体シェル(ZnS)でコーティングして作られています。CdSeTeを含むQdot™ 705およびQdot™ 800ストレプトアビジンコンジュゲートの製造方法も同様です。このコアシェル材料はさらにポリマーシェルでコーティングされており、生体分子に結合して、その光学特性を保持できます。

ストレプトアビジンの他の蛍光コンジュゲート
他にも数種類のQdot™カラーをご用意しています。6色のQdot™ストレプトアビジンコンジュゲート(525、565、585、605、655、705)を含むQdot™ストレプトアビジンサンプラーキットもお試しください。ナノクリスタルコンジュゲートに加えて、Alexa Fluor™色素、Oregon Green™色素、酵素コンジュゲート、Texas Red™色素、フルオレセイン(FITC)などの従来のフルオロフォアに結合した幅広いストレプトアビジンを提供しています。

ビオチン化コンジュゲートを探す
当社では、ビオチン-ストレプトアビジン検出戦略に使用するビオチン化コンジュゲートの幅広いラインアップを提供しています。
一次抗体検索ツールを使用して、ビオチン化一次抗体を見つけます
二次抗体セレクターツールを使用して、ビオチン化二次抗体、ビオチン化抗色素、抗ハプテン抗体を見つけます

内因性ビオチンのブロック
天然に存在するビオチンは、ビオチン-ストレプトアビジン検出スキームを妨げる可能性があります。固定および透過処理した細胞が必要な実験では、この干渉を最小限に抑えるために、当社の内因性ビオチンブロッキングキットをお試しください。

本製品は研究用試薬です。ヒトまたは動物の治療または診断用には使用できません。

関連リンク:

Avidin-Biotin Detectionの詳細を見る

Qdot™ナノクリスタルの詳細を見る
研究用にのみ使用できます。診断用には使用いただけません。
仕様
濃度1 μm
製品タイプストレプトアビジンコンジュゲート(蛍光)
数量50 μL
出荷条件室温
コンジュゲートQdot 605
形状液体
製品ラインQdot
Unit SizeEach
組成および保存条件
1チューブ—2~6°Cで保管します;凍結させないでください

よくあるご質問(FAQ)

I am getting very high background with my Qdot streptavidin conjugate. Do you have any suggestions?

Here are some suggestions: Use the Qdot Incubation Buffer (Cat. No. Q20001MP). The included buffer is formulated specifically for improved signal-to-background ratios in most immunolabeling applications using the Qdot streptavidin conjugates. Alternate buffers may result in more variable staining and, in particular, may increase background staining. However, some specific applications may require other buffer conditions. Please see the protocol "Double-labeling Using Qdot Streptavidin conjugates."
Determine if the sample has a high level of endogenous biotin. Block the sample using an avidin-biotin pre-blocking step.
If you have used the Qdot Incubation Buffer and still get high nonspecific background, then it may be necessary to check other steps of your procedure. Blocking the sample with BSA or normal animal serum will generally decrease nonspecific binding of both antibodies and Qdot streptavidin conjugates. It is a good practice to dilute your primary and secondary antibodies in the blocking buffer. Some tissues such as spleen and kidney sections may contain endogenous biotin, which may contribute to non-specific signal. Endogenous biotin can be blocked with an avidin/biotin blocking kit (Cat. No. E21390).
Grainy staining or clumps of fluorescent material appear in the background.
Occasionally the BSA within the Qdot Incubation Buffer shows slight aggregation over time. It is necessary to remove this aggregate prior to labeling the sample with the Qdot streptavidin conjugate. Spin down the incubation mixture before addition to the sample. This can be accomplished by spinning the samples in a benchtop centrifuge (Eppendorf 5415) at 5,000 x g for 2 minutes. The material can also be passed over a 0.2 µm spin filter unit before you add it to the sample for staining to remove microscopic precipitates. If you are using a buffer that is different than the Qdot Incubation Buffer, this behavior can often be attributed to higher levels of NaCl or other salts in the incubation buffer, and may not be easily fixed with filtration. In this case, reduce the overall salt concentration.
Optimize concentration of biotinylated secondary antibodies.
Optimizing specific signal can often be achieved by adjusting the level of biotinylated antibody used instaining. High levels of biotinylated antibody are necessary to obtain specific labeling, but overly high levels will contribute to nonspecific binding of the antibody to the sample. Nonspecifically bound biotinylated antibody will bind to the Qdot streptavidin conjugate, resulting in higher staining of the background.
Optimize concentration of Qdot streptavidin conjugate.
Just as titration of primary and secondary antibodies is necessary to achieve optimal specific signal in immunolabeling applications, the level of the final probe should be optimized for each conjugate. In general, concentrations at or slightly below saturation should have the optimal signal-to-background ratio, while concentrations substantially higher than saturation will compromise the assay with higher background levels.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

I am getting no signal with my Qdot streptavidin conjugate. What should I do?

Here are some suggestions:

Confirm imaging/detection setup suitability.
Make sure that you are using an appropriate filter set to detect the signal. Please consult Table 1 in the Qdot Biotin User Manual for a list of appropriate and optimal filters.
Check to see that Qdot conjugate is fluorescing using an alternative light source.
Qdot conjugates will normally fluoresce brightly under a hand-held ultraviolet lamp (long wave, such as the type used to visualize ethidium bromide on agarose gels). Although we have not seen pronounced loss of fluorescence of these materials under any storage conditions that we have investigated, we have not been able to examine all storage conditions. If the Qdot product does not appear to fluoresce under the long wave UV excitation, please contact Technical Support at techsupport@qdots.com. For a microscope, perform a spot test: place a small droplet (2 to 5 µL) of the quantum dot solution onto a clean slide (no coverslip) and examine under the appropriate filter set at low magnification.
Confirm the specificity and titer of primary antibody.
Make sure the antibody will recognize the intended targets. Make sure there is sufficient primary antibody bound to the targets. This verification can be performed by ELISA-based capture of the antigen of interest, or by other techniques that can be found in lab manuals such as the Current Protocols in Immunology.
For Qdot streptavidin conjugates, confirm biotinylation of antibody.
Make sure your antibodies are effectively biotinylated. It may be necessary to independently adjust the concentration of both the primary and secondary antibodies used in the assay to obtain optimal signal and minimal background.
PAP pen ink may quench signal.
Use an alternate method for isolating target areas on the slide. If your protocol requires the use of a PAP pen, we recommend the ImmEdge Hydrophobic Barrier Pen (Cat. No. H-4000) from Vector Labs.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

What is the best way to remove white precipitate from my ITK Qdot nanocrystals?

Spinning your ITK Qdot nanocrystals at approximately 3,000 rpm for 3-5 minutes should remove the white precipitate from the supernatant. Use the supernatant immediately.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

I see a white precipitate in my ITK Qdot nanocrystals; should I be concerned?

The precipitate in the organic ITK Qdot nanocrystals occurs with some frequency. The ITK Qdot nanocrystals sometimes include impurities that show as a white precipitate.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

Why do my Qdot nanocrystals appear to be blinking?

Blinking is an inherent property of quantum dots; in fact, all single-luminescent molecules blink, including organic dyes. The brightness and photostability of Qdot nanocrystals makes the blinking more visibly apparent. Under higher energy excitation, Qdot nanocrystals blink even faster.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

引用および参考文献 (9)

引用および参考文献
Abstract
Helios marks strongly autoreactive CD4+ T cells in two major waves of thymic deletion distinguished by induction of PD-1 or NF-?B.
Authors:Daley SR, Hu DY, Goodnow CC,
Journal:J Exp Med
PubMed ID:23337809
'Acquisition of self-tolerance in the thymus requires T cells to discriminate strong versus weak T cell receptor binding by self-peptide-MHC complexes. We find this discrimination is reported by expression of the transcription factor Helios, which is induced during negative selection but decreases during positive selection. Helios and the proapoptotic protein ... More
B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A.
Authors:Bergmann H, Yabas M, Short A, Miosge L, Barthel N, Teh CE, Roots CM, Bull KR, Jeelall Y, Horikawa K, Whittle B, Balakishnan B, Sjollema G, Bertram EM, Mackay F, Rimmer AJ, Cornall RJ, Field MA, Andrews TD, Goodnow CC, Enders A,
Journal:J Exp Med
PubMed ID:23267016
Druggable proteins required for B lymphocyte survival and immune responses are an emerging source of new treatments for autoimmunity and lymphoid malignancy. In this study, we show that mice with an inactivating mutation in the intramembrane protease signal peptide peptidase-like 2A (SPPL2A) unexpectedly exhibit profound humoral immunodeficiency and lack mature ... More
'In parallel' interconnectivity of the dorsal longitudinal anastomotic vessels requires both VEGF signaling and circulatory flow.
Authors:Zygmunt T, Trzaska S, Edelstein L, Walls J, Rajamani S, Gale N, Daroles L, Ramírez C, Ulrich F, Torres-Vázquez J,
Journal:J Cell Sci
PubMed ID:22899709
Blood vessels deliver oxygen, nutrients, hormones and immunity factors throughout the body. To perform these vital functions, vascular cords branch, lumenize and interconnect. Yet, little is known about the cellular, molecular and physiological mechanisms that control how circulatory networks form and interconnect. Specifically, how circulatory networks merge by interconnecting 'in ... More
Single-molecule protein arrays enabled by scanning probe block copolymer lithography.
Authors:Chai J, Wong LS, Giam L, Mirkin CA,
Journal:Proc Natl Acad Sci U S A
PubMed ID:22106270
The ability to control the placement of individual protein molecules on surfaces could enable advances in a wide range of areas, from the development of nanoscale biomolecular devices to fundamental studies in cell biology. Such control, however, remains a challenge in nanobiotechnology due to the limitations of current lithographic techniques. ... More
Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo.
Authors:Mandraju R, Murray S, Forman J, Pasare C,
Journal:
PubMed ID:24688022
TLR activation on dendritic cells (DCs) induces DC maturation and secretion of proinflammatory cytokines, both of which are important for activation and differentiation of CD4 T cells. The importance of TLR activation on DCs for CD8 T cell responses is less clear. In this study, we tested the ability of ... More